Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Terbinafine 1% gel |
| BNF code | 131002030AAACAC |
| Virtual Therapeutic Moiety | Terbinafine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Terbinafine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 10.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | gel.cutaneous |
| Dose Form | |
| Formulation | Cutaneous gel |
| Drug Route | |
| Route | Cutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Lamisil AT 1% gel (Karo Healthcare UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Terbinafine 1% gel 15 gram | |
dm+d data retrieved from TRUD: release NHSBSA_1.2.0_20250113000001, imported on 14th January 2025 at 04:06:47.